AmerisourceBergen (ABC) Tops Q2 EPS by 16c, Revenues Miss; Raises FY19 EPS Guidance

AmerisourceBergen (NYSE: ABC) reported Q2 EPS of $2.11, $0.16 better than the analyst estimate of $1.95. Revenue for the quarter came in at $43.3 billion versus the consensus estimate of $43.63 billion.

• Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year
• Second Quarter GAAP Diluted EPS of $0.13 and Adjusted Diluted EPS of $2.11
• Adjusted Diluted EPS Guidance Range Raised to $6.70 to $6.90 for Fiscal 2019

“AmerisourceBergen continues to execute and deliver strong performance with good growth in customer volumes, double-digit Specialty distribution growth and overall strong execution across both the Pharmaceutical Distribution Services and Global Commercialization Services & Animal Health groups this quarter,” said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen.

“As we move into the second half of the year, our fiscal 2019 outlook remains strong,” Mr. Collis continued. “AmerisourceBergen continues to be well positioned for long-term growth and we have the utmost confidence that our differentiated strategy and focus on providing innovative services and solutions for our partners will continue to drive sustainable value for all of our stakeholders.”

GUIDANCE:

AmerisourceBergen sees FY2019 EPS of $6.70-$6.90, versus the consensus of $6.76.

For earnings history and earnings-related data on AmerisourceBergen (ABC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c